PAVmed, Inc. PAVM 深 滬
等待開盤 01-28 09:30:00 美东时间
8.65
-0.690
-7.39%
華盛通- 最 高9.70
- 今 開9.11
- 成交量 18.62万股
- 最 低 8.65
- 昨 收 9.34
- 總市值 855.57万
- 52周最高 28.44
- 市盈率 靜 0.58
- 換手率 18.82%
- 52周最低 6.00
- 委 比 -89.67%
- 總股本 98.91万
- 歷史最高 6841.5963
- 量 比 0.02
- 振 幅 11.24%
- 歷史最低 6.00
- 每 手 1
- 風險率 4.76%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多What's Going On With PAVmed Shares Thursday?
PAVmed shares pull back Thursday, possibly retracing recent gains on news its subsidiary, Lucid Diagnostics secured a contract
01-22 22:23
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers PAVmed (NASDAQ:PAVM) stock increased by 250.7% to $21.71 during Wednes...
01-22 01:05
Why Is PAVmed Stock Skyrocketing Wednesday?
Pavmed Inc. (PAVM) surges as its subsidiary Lucid Diagnostics (LUCD) secures a contract with VA for its cancer prevention test.
01-22 00:22
Lucid Diagnostics Wins VA Contract For EsoGuard, Expanding Esophageal Cancer Screening Across Nationwide VA Healthcare System
Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced that it has been
01-21 21:10
PAVmed announces 1-for-30 reverse stock split
PAVmed (PAVM) will conduct a 1-for-30 reverse stock split of its common stock, effective on January 2, 2026, at 12:01 a.m. Eastern Time. The reverse stock split is intended to bring the company into c...
2025-12-30 22:29
PAVmed To Execute 1-For-30 Reverse Stock Split, Effective January 2, 2026
PAVmed Inc. (NASDAQ:PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced it
2025-12-30 22:03
PAVmed Announces Reverse Stock Split
NEW YORK, Dec. 30, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, di...
2025-12-30 22:01
美股大行评级 | 超配！大摩上调回声星通信评级；汽车地带、CBRL、金宝汤、家得宝等遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8美元升至8.25美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12.5美元升至13美元
2025-12-11 10:33
Ascendiant Capital Maintains Buy on PAVmed, Lowers Price Target to $17
Ascendiant Capital analyst Edward Woo maintains PAVmed (NASDAQ:PAVM) with a Buy and lowers the price target from $20 to $17.
2025-12-10 18:27
PAVmed Approves Reverse Stock Split Amendment
PAVmed ( ($PAVM) ) has issued an update. On December 5, 2025, PAVmed Inc. held ...
2025-12-06 05:53
